Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 250706

Quetiapine augmentation in treatment-resistant depression : a naturalistic study


Šagud, Marina; Mihaljević-Peleš, Alma; Muck-Šeler, Dorotea; Jakovljević, Miro; Pivac, Nela
Quetiapine augmentation in treatment-resistant depression : a naturalistic study // Psychopharmacology, 187 (2006), 4; 511-514 doi:10.1007/s00213-006-0452-x (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 250706 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Quetiapine augmentation in treatment-resistant depression : a naturalistic study

Autori
Šagud, Marina ; Mihaljević-Peleš, Alma ; Muck-Šeler, Dorotea ; Jakovljević, Miro ; Pivac, Nela

Izvornik
Psychopharmacology (0033-3158) 187 (2006), 4; 511-514

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
treatment resistant depression; quetiapine; add-on therapy

Sažetak
Rationale Treatment resistant depression (TRD) is a common clinical problem, often complicated with suicidal ideations and greater lifetime functional impairment, and represents a considerable challenge to management and treatment. Objective The aim of a prospective, open-label, non-comparative, flexible-dosed 20-week study was to evaluate the effects of quetiapine, as an add-on therapy, in patients with TRD who were refractory to previous treatments. Method Eighteen patients with major depressive disorder (DSM-IV criteria) were treated for 20 weeks with quetiapine (mean dose 315 ± ; ; ; 109 mg/day). Patients were evaluated at baseline, weekly from 1-9 week, and than after 12, 16 and 20 weeks of treatment, using Hamilton Rating Scale for Depression-17 items (HAMD) scale. Results Fourteen patients with TRD completed the 20-week open trial with quetiapine. The augmentation with quetiapine significantly reduced total scores and scores listed in the anxiety subscale on the HAMD, and these effects were observed after the fourth week of treatment, while the depressed mood scores were significantly reduced after fifth week of treatment. Quetiapine add-on treatment significantly decreased the scores listed in the insomnia subscale on the HAMD subscale after second week of treatment. Conclusions Our preliminary data indicate that quetiapine add-on therapy appears to have beneficial effects in the treatment of patients with TRD.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
0098088
0108106

Ustanove
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Rijeka

Citiraj ovu publikaciju

Šagud, Marina; Mihaljević-Peleš, Alma; Muck-Šeler, Dorotea; Jakovljević, Miro; Pivac, Nela
Quetiapine augmentation in treatment-resistant depression : a naturalistic study // Psychopharmacology, 187 (2006), 4; 511-514 doi:10.1007/s00213-006-0452-x (međunarodna recenzija, članak, znanstveni)
Šagud, M., Mihaljević-Peleš, A., Muck-Šeler, D., Jakovljević, M. & Pivac, N. (2006) Quetiapine augmentation in treatment-resistant depression : a naturalistic study. Psychopharmacology, 187 (4), 511-514 doi:10.1007/s00213-006-0452-x.
@article{article, year = {2006}, pages = {511-514}, DOI = {10.1007/s00213-006-0452-x}, keywords = {treatment resistant depression, quetiapine, add-on therapy}, journal = {Psychopharmacology}, doi = {10.1007/s00213-006-0452-x}, volume = {187}, number = {4}, issn = {0033-3158}, title = {Quetiapine augmentation in treatment-resistant depression : a naturalistic study}, keyword = {treatment resistant depression, quetiapine, add-on therapy} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka:


  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font